Business Wire

Spatial Announces the Release 2026 1.0.1: New Enhancements Across 3D InterOp, Data Prep, Meshing, and 3D Modeling SDKs

24.4.2026 16:21:00 EEST | Business Wire | Press release

Share

Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced new enhancements across several of its product lines. These updates further strengthen Spatial’s commitment to delivering high-performance solutions that optimize interoperability, data preparation, and advanced modeling workflows.

Designed to improve efficiency and robustness across CAD translation, modeling, meshing, and simulation processes, the latest updates introduce expanded format support, enhanced PMI handling, and new capabilities for complex geometry processing.

3D InterOp

NX Reader Enhancement for 2D Drawings

The NX reader imports 2D drawings as visualization data from NX 2412 and later versions.

glTF Writer Supports Draco Compression

glTF export incorporates Draco compression for meshes and point-clouds to significantly reduce output file sizes.

Enhanced Support for Reading Product Manufacturing Information (PMI)

  • The STEP Reader supports graphical PMI at the assembly level.
  • The JT Reader supports semantic PMI at the assembly level.
  • The NX Reader supports PMI created in drafting mode when attached to a solid (PMI attached to drawing sheets are excluded).

Updated CAD Format Version Support

  • JT 10.11
  • NX 2512
  • Solid Edge 2026

Data Prep

Hidden Body Removal (HBR)

HBR extends support for assembly models within UConnect workflows to several CAD formats like Solid Edge and Revit as well as for mesh formats like 3MF, OBJ and Smart 3D.

3D ACIS Modeler

Blending (Filleting) Enhancements

  • Rho-Conic Cross-Sections: Create blends with conic cross-sections defined by a rho-parameter.
  • Enhanced robustness when simultaneously processing multiple edge sequences: Improves stability and prevents overlaps and interference between blends.

Resolution of Edge Self-Intersections

Enable checking and optional splitting of edges with self-intersections.

Mesh Prep for ACIS

Mesh Prep for ACIS is an add-on for ACIS that provides tools to simplify the pre-processing of CAD geometry for simulation workflows. Enhancements in Mesh Prep for ACIS for computing centerlines include:

  • Handling of Concentric Faces
    For pipes with concentric inner and outer walls, ACIS now calculates a unique centerline automatically.
  • Joints and Branches
    Generation of centerlines now handles more complex cases with joints and branches.

Mesh Prep for ACIS requires an additional license.

3D CGM Modeler

Curve Self-Intersection Checker

Detects self-intersections of a curve and optionally splits them to obtain a wire body with the same shape as the input curve in scenarios where a surface on which the input curve lies is known.

Filleting Aids

Documentation improvements including new sample code are available that provide more clarity and guidance for the creation of fillets.

CSM Surface Mesher and CVM Volumetric Mesher

CSM: Mesh Healing

Mesh healing functionality in CSM enables robust downstream simulation workflows. The operator prepares for volume meshing by automatically resolving invalid intersections, self-intersections or gaps in the input surface mesh.

CSM-CVM: Interface for Mesh-Quality Evaluation

A new mesh quality evaluator enables surface and volume mesh analysis via predefined or custom quality metrics.

CSM-CVM: Samples for Adaptive Meshing

Documentation and package enhancements, including new samples, are available for adaptive surface and volume meshing workflows.

About Spatial Corp.

Spatial Corp., a Dassault Systèmes subsidiary, is the leading provider of 3D software development toolkits for technical applications across a broad range of industries. Spatial 3D modeling, CAD translation, Meshing and 3D visualization software development toolkits help application developers deliver market-leading products, maintain focus on core competencies, and reduce time-to-market. For over 35 years, Spatial’s 3D software development toolkits have been adopted by many of the world’s most recognized software developers, manufacturers, research institutes, and universities. Headquartered in Broomfield, Colorado, Spatial has offices in the USA, France, Germany, Japan, China, and the United Kingdom. For more information on Spatial’s latest updates and product offerings, please visit www.spatial.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260424111656/en/

Contacts

Spatial Corp Press Contact
Feriel JEDIDI DUPONT
+33 1 6162 8201
Feriel.JEDIDI@3ds.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye